J2267 Injection, mirikizumab-mrkz, 1 mg

Billable / valid for submission HCPCS Release 2026Q3

Short description: Inj, mirikizumab-mrkz, 1 mg

Version history

Related codes in J22

• J2210 Injection, methylergonovine maleate, up to 0.2 mg
• J2212 Injection, methylnaltrexone, 0.1 mg
• J2246 Injection, micafungin in sodium (baxter), not therapeutically equivalent to j2248, 1 mg
• J2247 Injection, micafungin sodium (par pharm) not thereapeutically equivalent to j2248, 1 mg
• J2248 Injection, micafungin sodium, 1 mg
• J2249 Injection, remimazolam, 1 mg
• J2250 Injection, midazolam hydrochloride, per 1 mg
• J2251 Injection, midazolam in 0.9% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mg
• J2252 Injection, midazolam in 0.8% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mg
• J2253 Injection, midazolam (seizalam), 1 mg
• J2260 Injection, milrinone lactate, 5 mg
• J2265 Injection, minocycline hydrochloride, 1 mg
• J2270 Injection, morphine sulfate, up to 10 mg
• J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg
• J2274 Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg
• J2277 Injection, motixafortide, 0.25 mg
• J2278 Injection, ziconotide, 1 microgram
• J2280 Injection, moxifloxacin, 100 mg
• J2281 Injection, moxifloxacin (fresenius kabi), not therapeutically equivalent to j2280, 100 mg
• J2290 Injection, nafcillin sodium, 20 mg

All J22 codes →